The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Accumulation of metformin by tissues of the normal and diabetic mouse
Abstract
1. Tissue accumulation of the antihyperglycaemic agent metformin (dimethylbiguanide) was examined after oral administration to the normal and streptozotocin (STZ) diabetic mouse. 2. Metformin (50 mg/kg body weight containing 14C-metformin 25 microCi/kg body weight), which is stable and not metabolized, resulted in maximum plasma concentrations at 0.5 h which declined to < 5% of maximum by 24 h. Maximum plasma concentrations (mumol/l, mean +/- SE) in the hepatic portal vein (normal 51.7 +/- 5.4, STZ 61.5 +/- 8.0) were higher than in the inferior vena cava (normal 29.0 +/- 2.8, STZ 35.4 +/- 5.9). 3. The greatest accumulation of metformin occurred in tissues of the small intestine, where maximum concentrations were > 1000 mumol/kg wet weight at 0.5-2 h, but declined to < 2% of maximum by 24 h. 4. Stomach, colon, salivary gland, kidney and liver accumulated metformin more than two-fold, and concentrations of the drug in heart and skeletal (gastrocnemius) muscle were greater than plasma concentrations on some occasions up to 8 h. 5. In a separate study, i.v.-administered metformin was selectively accumulated by tissues of the small intestine. Thus, retention of metformin by tissues of the small intestine may represent a deep compartment for the drug.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In both studies, Arunachalam et al. (110) and Ghosh et al. (111) used 50 μM metformin and justified this concentration on the basis that estimates of metformin levels in the portal circulation following oral absorption are between 40 and 70 μM (4, 181).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [181]
Citations
Cites
Singh, B. N., Ellrodt, G. A., & Peter, C. T. (1978) · Drugs · doi:10.2165/00003495-197815030-00001 · Cited by 835
Bailey, C. J. (1992) · Diabetes Care · doi:10.2337/diacare.15.6.755 · Cited by 593
Self-citationMetformin kinetics in healthy subjects and in patients with diabetes mellitus.
Tucker, G., Casey, C., Phillips, P., Connor, H., Ward, J. D., & Woods, H. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01206.x · Cited by 503
Pharmacokinetics of Metformin After Intravenous and Oral Administration to Man
Pentik�inen, P. J., Neuvonen, P. J., & Penttil�, A. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562061 · Cited by 348
Disposition of metformin (N,N‐dimethylbiguanide) in man
Sirtori, C. R., Franceschini, G., Galli-Kienle, M., Cighetti, G., Galli, G., Bondioli, A., & Conti, F. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978246683 · Cited by 222
Metformin: a review of its pharmacological properties and therapeutic use.
Ls, H. (1979) · PubMed · Cited by 175
Determination of glucose by an automatic analyser
Stevens, J. F. (1971) · Clinica Chimica Acta · doi:10.1016/0009-8981(71)90332-9 · Cited by 166
Konturek, S. J. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-789_4 · Cited by 158
Effect of metformin on glucose metabolism in the splanchnic bed
Bailey, C. J., Wilcock, C., & Day, C. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09093.x · Cited by 131
Self-citationMetformin in the digestive tract
Vidon, N., Chaussade, S., Noël, M., Franchisseur, C., Huchet, B., & Bernier, J. J. (1988) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(88)80022-6 · Cited by 117
Research works printed but not linked: 7
- Bailey C. J., 1988, Balliere's Clinical Endocrinology and Metabolism, 2, 455
- Bailey C. J., 1986, Diabete et Metabolisme, 12, 212
- Cigolini M., 1984, Diabete et Metabolisme, 10, 311
- Cohen P. Y., 1961, Therapie, 16, 109
- Hermann L. S, 1979, Diabete et Metabolisme, 5, 233
- Mordes J. P., 1985, Joslin's Diabetes Mellitus12th edn, 110
- Noel M, 1979, Research and Clinical Forums, 1, 35
Cited by
Sorted by citations
Items 301–400 of 414
Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights
Sarkar, A., Fanous, K., Marei, I., Ding, H., Ladjimi, M. M., MacDonald, R. S., Hollenberg, M. D., Anderson, T. J., Hill, M. A., & Triggle, C. R. (2024) · Vascular Health and Risk Management · doi:10.2147/vhrm.s391808 · Cited by 11
Díez, R., Garcia, J. J., Diez, M. J., Sierra, M., Sahagún, A. M., & Fernández, N. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1809-x · Cited by 11
Gomes, M. B., Cailleaux, S., & Tibiriçá, E. V. (2005) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-005-1083-1 · Cited by 11
Anti-obesity and metabolic benefits of metformin: Comparison of different delivery routes
Abbasi, M., Fan, Z., Dawson, J., & Wang, S. F. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105110 · Cited by 10
Metformin: Antidiabetic actions from cells to tissues
Bailey, C. J., Gwilt, M., & Brand, K. M. G. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156589 · Cited by 10
Self-citationMetformin Transport Rates Between Plasma and Red Blood Cells in Humans
Kurlovičs, J., Zake, D. M., Zaharenko, L., Berzins, K., Kloviņš, J., & Stalidzāns, E. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-021-01058-2 · Cited by 11
Rezaei, S., Timani, K. A., & He, J. J. (2023) · Aging and Disease · doi:10.14336/ad.2023.0705 · Cited by 10
Metformin's Impact on the Microvascular Response to Insulin
Love, K. M., Barrett, E. J., & Horton, W. B. (2022) · Endocrinology · doi:10.1210/endocr/bqac162 · Cited by 10
Metformin Accelerates Glycolytic Lactate Production in Cultured Primary Cerebellar Granule Neurons
Blumrich, E., & Dringen, R. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2346-1 · Cited by 10
Metformin Exerts Beneficial Effects in Hemorrhagic Shock in An AMPKα1-Independent Manner
Kim, P., Piraino, G., O’Connor, M. P., Hake, P. W., Wolfe, V., Lahni, P. M., & Zingarelli, B. (2017) · Shock · doi:10.1097/shk.0000000000000984 · Cited by 10
Peuler, J. D., Lee, J. M., & Smith, J. M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00522-6 · Cited by 10
Metformin: A possible drug for treatment of endometrial cancer
Tsuji, K., Kisu, I., Banno, K., Yanokura, M., Ueki, A., Masuda, K., Kobayashi, Y., Yamagami, W., Nomura, H., Susumu, N., et al. (2012) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2012.21001 · Cited by 9
Metformin retention independent of renal failure in intestinal occlusion.
Lalau, J., Race, J., Andréelli, F., Lacroix, C., & Canarelli, J. P. (2001) · PubMed · Cited by 9
Antidiabetes drug metformin is a donor of nitric oxide: EPR measurement of efficiency
Сереженков, В. А., Кузнецов, И. С., Romantsova, T. I., Кузнецова, М., & Vanin, A. F. (2011) · BIOPHYSICS · doi:10.1134/s0006350911060169 · Cited by 9
Impact of currently used anti-diabetic drugs on myoendothelial communication
Ding, H., Ye, K., & Triggle, C. R. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.11.002 · Cited by 9
Maciejczyk, A., & Blecharz‐Klin, K. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118743 · Cited by 8
Prescription drugs and mitochondrial metabolism
Schmidt, C. A. (2022) · Bioscience Reports · doi:10.1042/bsr20211813 · Cited by 8
Energy Metabolism and Metformin: Effects on Ischemia-Reperfusion Injury in Kidney Transplantation
Nemeth, D. V., Iannelli, L., Gangitano, E., D’Andrea, V., & Bellini, M. I. (2024) · Biomedicines · doi:10.3390/biomedicines12071534 · Cited by 8
Rescher, L., Singh, S., Zahn, I., Paulsen, F. P., & Schicht, M. (2024) · Life · doi:10.3390/life14121682 · Cited by 8
Deciphering metformin action in obese mice: A critical re-evaluation of established protocols
Kaplanian, M., Philippe, C., Eid, S. A., Hackl, M. T., Metz, M., Beghini, M., Luca, A. C., Kautzky‐Willer, A., Scherer, T., & Fürnsinn, C. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154956 · Cited by 8
Ma, Y., Shi, A., Qin, H., Zhang, T., Wu, Y., Zhang, G., & Wu, X. (2016) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2041 · Cited by 8
Mécanisme d’action hépatique de la metformine dans le diabète de type 2
Foretz, M., & Viollet, B. (2009) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(09)70104-x · Cited by 12
de Laat, M. A., & Sillence, M. N. (2020) · Animal Production Science · doi:10.1071/an19491 · Cited by 7
Aladhab, R. A., Abd, A. H., Alidrisi, H. A., & Alabbood, M. (2023) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2699 · Cited by 7
Brand, K. M. G., Schlachter, J., Foch, C., & Boutmy, E. (2022) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s372430 · Cited by 7
A purinergic mechanism underlying metformin regulation of hyperglycemia
Senfeld, J. I., Peng, Q., Shi, Y. P., Qian, S., & Shen, J. (2023) · iScience · doi:10.1016/j.isci.2023.106898 · Cited by 7
Time course and dose effect of metformin on weight in patients with different disease states
Chen, X., Wang, D., & Li, Z. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1822164 · Cited by 7
Proctor, W. R. (2010) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/a54k-5s46 · Cited by 7
In vitro anti-echinococcal activity of octreotide: Additive effect of metformin linked to autophagy
Loos, J. A., Negro, P., & Cumino, A. C. (2019) · Acta Tropica · doi:10.1016/j.actatropica.2019.105312 · Cited by 7
Inverse relationship between peripheral insulin removal and action: studies with metformin
Zhang, Z., & Radziuk, J. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1240 · Cited by 7
Metformin induces a Lac-Phe gut–brain signalling axis
TeSlaa, T. A. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01014-x · Cited by 7
Otowa‐Suematsu, N., Sakaguchi, K., Yamada, T., Nishisaka, M., Morita, Y., Fukumitsu, H., Katsura, Y., Okada, Y., Hirota, Y., Sugawara, K., et al. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005255 · Cited by 6
Mitochondrial Ca 2+ in Cancer Growth and Metabolism
Weissenrieder, J., & Foskett, J. K. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70093 · Cited by 6
Baskal, S., Posma, R. A., Bollenbach, A., Dieperink, W., Bakker, S. J. L., Nijsten, M. W., Touw, D. J., & Tsikas, D. (2024) · Amino Acids · doi:10.1007/s00726-024-03383-9 · Cited by 6
Analyses of Biguanides and Related Compounds in Biological and Environmental Samples by HPLC
Ali, I., Hussain, I., Sanagi, M. M., Ibrahim, W. A. W., & Aboul-Enein, H. Y. (2014) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2014.940803 · Cited by 6
Metformin alters therapeutic effects in the BALB/c tumor therapy model
Meyer, F., Goebel, S., Spangel, S. B., Leovsky, C., Hoelzer, D., & Thierbach, R. (2021) · BMC Cancer · doi:10.1186/s12885-021-08354-x · Cited by 6
Metabolic effects of pharmaceuticals in fish
Yeh, A., Meador, J. P., Lunsman, T. D., Mayfield, D. B., & Verslycke, T. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102971-8.00013-5 · Cited by 6
Glucose metabolism in mouse embryos exposed to metformin in vitro
Smoak, I. W. (1999) · Toxicology in Vitro · doi:10.1016/s0887-2333(98)00061-7 · Cited by 6
Metformin Boosts Intestinal Lipid Sensing via GIP to Suppress Feeding
Kuah, R., Wang, M. T., Yang, Z., Back, G., Li, R., Bruce, K., LoChoy, J. N., Beaudry, J. L., Barros, D. R., Zhang, S., et al. (2025) · Diabetes · doi:10.2337/db25-0100 · Cited by 5
Glucose Supply and Insulin Demand Dynamics of Antidiabetic Agents
Monte, S. V., Schentag, J. J., Adelman, M. H., & Paladino, J. A. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400219 · Cited by 5
Renal Trapping in Accidental Metformin Intoxication
Posma, R. A., Wessels, A. M. A., Dieperink, W., Roggeveld, J., Leuvenink, H. G. D., van der Horst, I. C. C., den Dunnen, W. F. A., Nijsten, M. W., & Touw, D. J. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.06.009 · Cited by 5
The Toxicity Effects of Metformin and the Bioremediation of Metformin in Aquatic Plant Duckweed
Han, B., Jiang, Y., Wang, W., Guo, Y., Yang, Y., He, Y., Di, Q., Qu, Z., Xing, Y., & Yang, L. (2025) · Plants · doi:10.3390/plants14121761 · Cited by 4
Neto, X. A. D. O., Barssotti, L., Fiori-Duarte, A. T., Barbosa, H. C. L., & Kawano, D. F. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220820151959 · Cited by 4
Loos, J. A., Negro, P., Ortega, H. H., Salinas, F. J., Arán, M., Pellizza, L., Salerno, G. L., & Cumino, A. C. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00941-24 · Cited by 5
The Antimalarial Drug Proguanil Is an Antagonist at 5-HT3 Receptors
Lochner, M., & Thompson, A. J. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218461 · Cited by 4
Imran, M., Sachdeva, G., Menon, S. R., Das, D. K., Davuluri, S., Acharya, K. K., & Chaudhari, U. K. (2022) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2022-0307 · Cited by 4
Antitumoral Effects of Metformin in Ovarian Cancer
Garrido, M. P., Vega, M., & Romero, C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88911 · Cited by 4
Bailey, C. J. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1331-8_8 · Cited by 4
Self-citationEffect of metformin on liver insulin metabolism and regional blood flow
Signore, A., Fiore, V., Chianelli, M., Ronga, G., & Pozzilli, P. (1995) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610110504 · Cited by 4
Durham, A. E. (2016) · Wiley eBooks · doi:10.1002/9781119169239.ch36 · Cited by 4
Neuroprotective Roles of Metformin in a Streptozotocin-Induced Dementia Model in Rats
Vizuete, A. F. K., Moreira, A. P., Zin, L. E. F., Marques, C. D. O., Pacheco, R. F., Leal, M. B., Menezes, L., & Gonçalves, C. (2025) · Neurotoxicity Research · doi:10.1007/s12640-025-00771-1 · Cited by 3
Metformin in advanced chronic kidney disease: are current guidelines overly restrictive?
Cole, N. I., Swift, P. A., Suckling, R., & Andrews, P. (2016) · British Journal of Diabetes · doi:10.15277/bjd.2016.106 · Cited by 3
Review on spectroscopic analytical methods for determination of metformin hydrochloride
Abood, N. K., Jamil, D. M., & Abass, A. M. (2020) · International Journal of Research in Engineering and Innovation · doi:10.36037/ijrei.2020.4203 · Cited by 3
Reduced Cytokine Tumour Necrosis Factor by Pharmacological Intervention in a Preclinical Study
Mooranian, A., Chester, J., Johnston, E., Ionescu, C. M., Walker, D. P., Jones, M., Wagle, S. R., Kovačević, B., Foster, T., Mikov, M., et al. (2022) · Biomolecules · doi:10.3390/biom12070877 · Cited by 3
Saguyod, S. J. U., Alhallak, I., Simmen, R. C. M., & Velarde, M. C. (2020) · Oncology Letters · doi:10.3892/ol.2020.12112 · Cited by 3
Yang, T., Wang, S., Zhang, X., Xia, J. L., Guo, J., Hou, J., Zhang, H., Chen, X., & Wu, X. (2016) · Korean Journal of Parasitology · doi:10.3347/kjp.2016.54.2.225 · Cited by 3
Metformin: od mehanizmov delovanja do napredne klinične uporabe
Janić, M., Volčanšek, Š., Lunder, M., & Janež, A. (2017) · Slovenian Medical Journal · doi:10.6016/zdravvestn.1503 · Cited by 4
Metformin: Historical Origins, Mechanisms of Action, and Emerging Clinical Applications
Hu, Y., Zhang, X., Yang, C., Wu, X., Ye, X., Yu, J. K., & Yang, Y. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70171 · Cited by 3
Stümvoll, M., Häring, H., & Matthaei, S. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-10 · Cited by 2
Üstün, F. (2019) · Nuclear Medicine Seminars · doi:10.4274/nts.galenos.2019.0005 · Cited by 3
Pieróg, M., Socała, K., Nieoczym, D., Wyska, E., Samorek-Pieróg, M., & Właź, P. (2023) · Molecules · doi:10.3390/molecules28093810 · Cited by 2
Ianus Bifrons: The Two Faces of Metformin
Goglia, U., Hasballa, I., Teti, C., Boschetti, M., Ferone, D., & Albertelli, M. (2024) · Cancers · doi:10.3390/cancers16071287 · Cited by 2
Натрус, Л. В., Klys, Y., Osadchuk, Y., Anft, M., Westhoff, T. H., & Babel, N. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04529-2 · Cited by 2
Lü, H. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0091-4 · Cited by 2
Metformin İntoksikasyonuna Bağlı Akut Böbrek Yetmezliği: Olgu Sunumu
Kocaoğlu, Ç., & Özel, A. (2018) · Türk yoğun bakım derneği dergisi/Türk yoğun bakım dergisi · doi:10.4274/tybd.26818 · Cited by 2
Should Pharmacokinetic Safety Challenges Prevent Metformin Use in Patients With Cancer?
Wintrob, Z. A. P. (2015) · Journal of Pharmacy Practice · doi:10.1177/0897190014559392 · Cited by 2
Metformin: Pharmacological Action and Nutritional Metabolism
Tanabe, K. (2024) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.77.327 · Cited by 1
Seo, E., Seo, H., & Lee, K. C. (2025) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2026.6.e6 · Cited by 1
Acidosis láctica y metformina. Tratamiento combinado con hemodiálisis y hemofiltración
López, J. C., Esteve, F., Jubert, E., Villanueva, H., & Pérez, X. L. (2007) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(07)71493-6 · Cited by 1
Кравчук, Е. Н., & Galagudza, M. M. (2013) · Diabetes Mellitus · doi:10.14341/2072-0351-3590 · Cited by 1
Maniar, K., Singh, V., Chakrabarti, A., Bhattacharyya, R., & Banerjee, D. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.05.013 · Cited by 1
Costales, C. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/v7v6-s548 · Cited by 1
Yenmiş, G. (2018) · AYDIN TIP FAKÜLTESİ KLİNİKLERİ DERGİSİ · doi:10.17932/iau.tfk.2018.008/2020.302/tfk_v03i2001 · Cited by 1
Paracelsus Paradox and Drug Repurposing for Cancer
Koltai, T. (2021) · Journal of Oncology Research · doi:10.30564/jor.v3i2.3649 · Cited by 1
Degaga, A., Sirgu, S., Huri, H. Z., Sim, M. S., Loganadan, N. K., Kebede, T., Tegene, B., Engidawork, E., & Shibeshi, W. (2024) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s457374 · Cited by 1
Кравчук, Е. Н., Grineva, E. N., Galagoudza, M. M., Kostareva, A. A., & Bairamov, A. A. (2012) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2012-18-3-206-212 · Cited by 1
Cantó, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811752-1.00017-1 · Cited by 1
Urhan, E., Temizer, E., Karaca, Z., Abdülrezzak, Ü., Kara, C. Ş., Hacıoğlu, A., & Ünlühızarcı, K. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01890-3 · Cited by 1
Functional analysis of hepatic FOXO3 signalling in glucose and lipid metabolism
Gul, S. (2014) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-3289 · Cited by 1
Courtois, S. (2017) · theses.fr (ABES) · doi:10.70675/9cea7a12z80a2z4c42za889z55d1acdfaf97 · Cited by 1
Arnol, V. (2012) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/2765
Effect of mucoadhesive delivery of metformin on the entero-insular axis
Adikwu, M. U., Attama, A. A., & Okorie, O. (2006) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(06)50024-3
Moleculair werkingsmechanisme van metformine: oude of nieuwe inzichten?
Rena, G., Pearson, E. R., & Sakamoto, K. (2013) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-013-0061-3
Effects of metformin on human monocytic THP-1 cells - Implications for type 2 diabetes mellitus
Tsuei, A.-C. (2010) · Research Commons (University of Waikato)
DIRECT EFFECTS OF METFORMIN ON PI3K AND RAS SIGNALING IN ENDOMETRIAL CANCER
Iglesias, & David, A. (2012)
Use of Metformin in Clomiphene Citrate (CC) Resistant Polycystic Ovary Syndrome (PCOS)
Begum, M. R., Banu, L. A., Rumana, R., Dewan, F., & Rouf, S. (2009) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1035
Mayer, M. (2016) · TSpace (University of Toronto)
Gillespie, Z. E. (2016) · University Library - University of Saskatchewan (University of Saskatchewan)
Usage of metformin in patients with type 2 diabetes mellitus
Huang, W. (2016) · UTAS Research Repository · doi:10.25959/23240615
Characterizing the Role of Insulin Signalling in Advanced Prostate Cancer
Sarkar, P. L. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.110524
Shen, M. (2013) · Human Biology
Multiple myeloma: treatment updates.
Berenson, J. R. (2013) · PubMed
Dite, T. A. (2018) · Minerva Access (University of Melbourne)
Investigating the Antidiabetic Effect of Metformin on Pyruvate Carboxylase
Solis, G. A. (2019) · Scholarship & Creative Works - Digital UNC a service of University Libraries (University of Northern Colorado)
Metformin modulates glucose uptake and transport in Caco-2 cell monolayers
Thakker, D. R., Bhatt, P. R., Costales, C., Everett, R. S., Alluri, R. V., Wung, D., & Mackowiak, B. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/0czr-eg59
Derkach, D. (2019) · TSpace (University of Toronto)
Faria, I. D. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2022.tde-28042022-085734
Metformin Inhibit Cell Proliferation and Secretion Function in NCI-H295R CellsPreprint
Li, C., Wang, F., Tong, A., Yan, Z., & Li, Y. (2020) · doi:10.21203/rs.3.rs-26937/v1
Morel, C. M. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717978474.793471035
Aschner, P. J. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726377451.793538285
Metadata
- Authors
- Wilcock, C., & Bailey, C. J.
- Affiliations
- Aston University (GB)
- ORCID
- Bailey, C. J.
- Venue
- Xenobiotica
- Publisher
- Informa UK Limited
- Published
- 1994-01
- Volume
- 24
- Issue
- 1
- Pages
- 49-57
- ISSN
- 0049-8254 (ISSN-L)
- 1366-5928
- OpenAlex
- W2136667764
- Cited by
- 418
- References
- 23
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 20 · 2023: 23 · 2022: 22 · 2021: 23 · 2020: 21 · 2019: 24 · 2018: 30 · 2017: 31 · 2016: 26 · 2015: 31 · 2014: 30 · 2013: 19 · 2012: 12
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Xenobiotica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, tissue accumulation, streptozotocin-induced diabetes, small intestine, drug retention, plasma concentration, oral administration, antidiabetic drugs, drug distribution
- MeSH terms
- Administration, Oral, Animals, Diabetes Mellitus, Experimental, Digestive System, Injections, Intravenous, Male, Metformin, Mice, Inbred Strains, Tissue Distribution, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review